𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequency of the hypercalcemia-leukocytosis syndrome in oral malignancies

✍ Scribed by Toshiyuki Yoneda; Riko Nishimura; Itsuro Kato; Masatoshi Ohmae; Masaaki Takita; Masayoshi Sakuda

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
593 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Factors predicting the acute effect of p
Factors predicting the acute effect of pamidronate on serum calcium in hypercalcemia of malignancy
✍ Stephen J. Gallacher; William D. Fraser; Fraser C. Logue; Frances J. Dryburgh; R πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 496 KB

In this study we retrospectively reviewed results of the first 9 days of treatment with pamidronate at doses of 30 mg (n = 13), 45 mg (n = 9), and 90 mg (n = 13) in an attempt to see what factors influenced the response of serum calcium to pamidronate. The nadir of serum calcium obtained post treatm

Trends in the incidence of acquired immu
Trends in the incidence of acquired immunodeficiency syndrome–related malignancies in Thailand
✍ Hutcha Sriplung; D. Maxwell Parkin πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 209 KB

## Abstract ## BACKGROUND Thailand was one of the first Asian countries to be affected by the epidemic of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS). Furthermore, Thailand possesses a national cancer surveillance system based upon regional cancer registries. ## MET

Timing of edentulation and extraction in
Timing of edentulation and extraction in the management of oral cavity and oropharyngeal malignancies
✍ Timothy D. Doerr; Mark T. Marunick πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 163 KB πŸ‘ 1 views

Background. Pretreatment dental evaluation is an essential element in the management of the head and neck cancer patient. Frequently, the dental condition requires edentulation or multiple extractions prior to radiotherapy. These extractions may be carried out at the time of oncologic resection. Suc

The use of oral BCG in the treatment of
The use of oral BCG in the treatment of metastatic malignant melanoma
✍ Pritchard, Kathleen I. ;Cowan, Donald H. ;Baker, Michael A. ;Osoba, David ;Phill πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

## Abstract This study assesses the effects of oral BCG, as a single agent, on tumor progression and on cell‐mediated immune function in patients with metastatic malignant melanoma. Thirty patients were studied including 22 with measurable metastatic lesions and 8 with no detectable disease, follow